SOL Price Prediction: Analysts Predict a Festive Boom for Solana and This New Crypto
Terns Pharma broadens beyond obesity drugs with upbeat data in leukemia trial
Terns Pharma broadens beyond obesity drugs with upbeat data in leukemia trial
Terns Pharmaceuticals Inc.’s stock jumped 7.5% premarket Tuesday, after the company announced positive data from an early-stage trial of a treatment for chronic myeloid leukemia.
